Bayer has agreed to a $7.25 billion deal to settle tens of thousands of lawsuits that its weedkiller Roundup caused cancer.
The big picture: Bayer — which acquired Roundup when it bought Monsanto in 2018 — announced Tuesday that it'll compensate people who allegedly suffered non-Hodgkin lymphoma due to exposure to Roundup.